This inventor holds 6 USPTO granted patents and 6 EPO patents. Top assignee: Merck Patent Gmbh. Active years: 2016-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2020
Title: Michael Busch: Innovator in Immunotherapy
Introduction
Michael Busch is a prominent inventor based in Darmstadt, Germany. He has made significant contributions to the field of immunotherapy, particularly through his innovative work on boronic acid derivatives. With a total of six patents to his name, Busch is recognized for his dedication to advancing medical treatments.
Latest Patents
Among his latest patents, Busch has developed compounds of formula (I) that serve as inhibitors of LMP7. These compounds can be employed for the treatment of autoimmune disorders and hematological malignancies. Additionally, he has worked on substituted boronic acids and boronate esters, which also act as immunoproteasome inhibitors, further contributing to potential therapies for serious health conditions.
Career Highlights
Michael Busch is currently associated with Merck Patent GmbH, where he continues to push the boundaries of scientific research and innovation. His work has not only advanced the understanding of immunotherapy but has also opened new avenues for treatment options in the medical field.
Collaborations
Busch collaborates with notable colleagues, including Oliver Poeschke and Markus Klein. Their combined expertise fosters a dynamic environment for innovation and research, enhancing the impact of their work in the industry.
Conclusion
Michael Busch stands out as a key figure in the realm of immunotherapy, with his patents paving the way for new treatments. His contributions reflect a commitment to improving healthcare through innovative solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile